Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory

Neuroscience

Volumn 154, Issue 2, 2008, Pages 454-460

  Pitsikas, N ^a   Boultadakis, A ^a   Sakellaridis, N ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

ketamine; object location; object recognition; rat; working memory

Indexed keywords

KETAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MALE; MEMORY DISORDER; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECOGNITION; SPATIAL MEMORY; TASK PERFORMANCE;

ANESTHETICS, DISSOCIATIVE; ANIMALS; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; KETAMINE; MALE; MEMORY; MEMORY, SHORT-TERM; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; RECOGNITION (PSYCHOLOGY); SPACE PERCEPTION;

EID: 46549088892     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.04.001     Document Type: Article

References (35)

1. Bartolini L., Casamenti F., and Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine and nucleus basalis lesions. Pharmacol Biochem Behav 53 (1996) 277-283
2. Carlsson M.L. Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways?. J Neural Transm 94 (1993) 1-10
3. Cavoy A., and Delacour J. Spatial but not object recognition is impaired by aging in rats. Physiol Behav 53 (1993) 527-530
4. de Lima M.N.M., Laranja D.C., Bromberg E., Roesler R., and Schroder N. Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats. Behav Brain Res 156 (2005) 139-143
5. Dere E., Huston J.P., and De Souza M.A. The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 31 (2007) 673-704
6. Ennaceur A., and Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data. Behav Brain Res 31 (1988) 47-59
7. Ennaceur A., Neave N., and Aggleton J.P. Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulated cortices, the medialprefrontal cortex, the cingulum bundle and the fornix. Exp Brain Res 113 (1997) 509-519
8. Geyer M.A. Behavioural studies of hallucinogenic drugs in animals: implications for schizophrenia research. Pharmacopsychiatry 31 (1998) 73-79
9. Grayson B., Idris N.F., and Neill J.C. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficits in the novel object recognition task in the rat. Behav Brain Res 184 (2007) 31-38
10. Imre G., Fokkema D.S., Den Boer J.A., and Ter Horst G.J. Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity. Brain Res Bull 69 (2006) 338-345
11. Javitt D.C., and Zukin R.S. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148 (1991) 1301-1308
12. Jones K.W., Bauerle L.M., and DeNoble V.J. Differential effects of σ and phencyclidine receptor ligands on learning. Eur J Pharmacol 179 (1990) 97-102
13. 2 receptors. Eur J Pharmacol 540 (2006) 53-56
14. Kos T., Popik P., Pietraszek M., Schafer D., Danysz W., Dravolina O., Blokhina E., Galankin T., and Bespalov A.Y. Effect of 5-HT3 receptor antagonist MDL72222 on behaviours induced by ketamine in rats and mice. Eur Neuropsychopharmacol 16 (2006) 297-310
15. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., and Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51 (1994) 199-214
16. Lalonde R., and Joyal C.C. Effects of ketamine and 1-glutamic acid diethyl ester on concept learning in rats. Pharmacol Biochem Behav 39 (1991) 829-833
17. Liy-Salmeron G., and Meneses A. Role of 5HT1-7 receptors in short- and long-term memory for an autoshaping task: Intrahippocampal manipulations. Brain Res 1147 (2007) 140-147
18. Long J.M., and Kessner R.P. Phencyclidine impairs temporal order memory for spatial location in rats. Pharmacol Biochem Behav 52 (1995) 645-648
19. Lorrain D.S., Baccei C.S., Bristow L.J., Anderson J.J., and Varney M.A. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117 (2003) 697-706
20. Mansbach R.S., and Geyer M.A. Parametric determinants in pre-stimulus modifications of acoustic startle: interaction with ketamine. Psychopharmacology 105 (1991) 162-168
21. Markowska A.L., Stone W.S., Ingram D.K., Reynolds J., Gold P.E., Conti L.H., Pontecorvo M.J., Wenk G.L., and Olton D.S. Individual differences in aging: behavioural and neurobiological correlates. Neurobiol Aging 10 (1989) 31-43
22. 1-7 receptors modulate short and long-term memory?. Neurobiol Learn Mem 87 (2007) 561-572
23. Moghaddam B., Adams B., Verma A., and Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17 (1997) 2921-2927
24. Nilsson M., Hansson S., Carlsson A., and Carlsson M.L. Differential effects of the N-methyl-D- aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice. Neuroscience 149 (2007) 123-130
25. Pichat P., Bergis O.E., Terranova J.P., Urani A., Duarte C., Santucci V., Guedet C., Voltz C., Steinberg R., Stemmelin J., Oury-Donat F., Avenet P., Griebel G., and Scatton B. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 32 (2007) 17-34
26. Pitsikas N., Zisopoulou S., and Sakellaridis N. Nitric oxide donor molsidomine attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801. J Neurosci Res 84 (2006) 299-305
27. Pitsikas N. Effects of scopolamine and L-NAME on rats' performance in the object location test. Behav Brain Res 179 (2007) 294-298
28. Razoux F., Garcia R., and Lena I. Ketamine at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutatmate release in the nucleus accumbens. Neuropsychopharmacology 32 (2007) 719-727
29. Robinson J.K., and Crawley J.N. Intraventricular galanin impairs delayed non-matching to sample performance in rats. Behav Neurosci 107 (1993) 458-467
30. Seeman P., Ko F., and Tallerico T. Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Mol Psychiatry 10 (2005) 877-883
31. Steckler T., Drinkenburg W.H.I.M., Sahgal A., and Aggleton J.P. Recognition memory in rats. I. Concepts and classification. Prog Neurobiol 54 (1998) 289-311
32. Tricklebank M.D., Singh L., Oles R.J., Preston C., and Iversen S.D. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167 (1989) 127-135
33. Uchihashi Y., Kuribara H., Isa Y., Morita T., and Sato T. The disruptive effects of ketamine on passive avoidance learning in mice: involvement of dopaminergic mechanism. Psychopharmacology 116 (1994) 40-44
34. Verma A., and Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 16 (1996) 373-379
35. Willetts J., Balster R.L., and Leander J.D. The behavioural pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 11 (1990) 423-428